nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Lethargy—Prednisone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Dicyclomine—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Dicyclomine—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Dicyclomine—Affect lability—Prednisone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Dicyclomine—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Dicyclomine—Face oedema—Prednisone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Dicyclomine—Mood swings—Prednisone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Dicyclomine—Muscular weakness—Prednisone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Dicyclomine—Abdominal distension—Prednisone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Dicyclomine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Dicyclomine—Lethargy—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Dicyclomine—Erythema—Prednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Dicyclomine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Dicyclomine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Dicyclomine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Dicyclomine—Mood swings—Methotrexate—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Dicyclomine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Dicyclomine—Hallucination—Betamethasone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Dicyclomine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Dicyclomine—Vision blurred—Prednisolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Dicyclomine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Dicyclomine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Dicyclomine—Erythema—Triamcinolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Dicyclomine—Erythema—Methylprednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Dicyclomine—Angioedema—Prednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Dicyclomine—Breast disorder—Methotrexate—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Dicyclomine—Malaise—Prednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Dicyclomine—Syncope—Prednisolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Dicyclomine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Dicyclomine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Dicyclomine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Dicyclomine—Hypertension—Prednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Dicyclomine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Dicyclomine—Discomfort—Prednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Dicyclomine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Dicyclomine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Dicyclomine—Erythema—Dexamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Dicyclomine—Erythema—Betamethasone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Dicyclomine—Hallucination—Prednisone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Dicyclomine—Malaise—Triamcinolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Dicyclomine—Malaise—Methylprednisolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Dicyclomine—Syncope—Triamcinolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Dicyclomine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Dicyclomine—Oedema—Prednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Dicyclomine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Dicyclomine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Dicyclomine—Shock—Prednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Dicyclomine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Dicyclomine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Dicyclomine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Dicyclomine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Dicyclomine—Eye disorder—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Dicyclomine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Dicyclomine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Dicyclomine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Dicyclomine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Dicyclomine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Dicyclomine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Dicyclomine—Angioedema—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Dicyclomine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Dicyclomine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Dicyclomine—Immune system disorder—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Dicyclomine—Malaise—Dexamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Dicyclomine—Malaise—Betamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Dicyclomine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Oedema—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Syncope—Betamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Syncope—Dexamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Shock—Triamcinolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Dicyclomine—Insomnia—Prednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Dicyclomine—Shock—Methylprednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Dicyclomine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Dicyclomine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Dicyclomine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Dicyclomine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Dicyclomine—Mental disorder—Prednisone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Dicyclomine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Dicyclomine—Erythema—Prednisone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Dicyclomine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Dicyclomine—Hypertension—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Dicyclomine—Discomfort—Dexamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Dicyclomine—Discomfort—Betamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Dicyclomine—Pain—Prednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Dicyclomine—Vision blurred—Prednisone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Dicyclomine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Dicyclomine—Oedema—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Dicyclomine—Oedema—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Dicyclomine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Dicyclomine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Dicyclomine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Dicyclomine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Dicyclomine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Dicyclomine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Dicyclomine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Dicyclomine—Shock—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Dicyclomine—Shock—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Dicyclomine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Dicyclomine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Dicyclomine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Dicyclomine—Agitation—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Dicyclomine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Dicyclomine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Dicyclomine—Angioedema—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Dicyclomine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Malaise—Prednisone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Dicyclomine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Dicyclomine—Syncope—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Dicyclomine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Dicyclomine—Anorexia—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Dicyclomine—Urticaria—Prednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Dicyclomine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Dicyclomine—Fatigue—Triamcinolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Dicyclomine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Dicyclomine—Pain—Triamcinolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Dicyclomine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Dicyclomine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Dicyclomine—Hypertension—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Dicyclomine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Dicyclomine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Dicyclomine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Insomnia—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Discomfort—Prednisone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Erythema—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Dicyclomine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Dicyclomine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Dicyclomine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Dicyclomine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Dicyclomine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Dicyclomine—Oedema—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Fatigue—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Shock—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Pain—Dexamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Pain—Betamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Tachycardia—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Dicyclomine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Dicyclomine—Anorexia—Prednisone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Dicyclomine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Dicyclomine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Dicyclomine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Dicyclomine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Dicyclomine—Malaise—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Dicyclomine—Urticaria—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Dicyclomine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Dicyclomine—Dizziness—Prednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Dicyclomine—Asthenia—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Dicyclomine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Dicyclomine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Dicyclomine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Dicyclomine—Insomnia—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Dicyclomine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Dicyclomine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Dicyclomine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Dicyclomine—Rash—Prednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Dicyclomine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Dicyclomine—Fatigue—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Dicyclomine—Headache—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Dicyclomine—Discomfort—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Dicyclomine—Constipation—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Dicyclomine—Confusional state—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Dicyclomine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Dicyclomine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Dicyclomine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Dicyclomine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Dicyclomine—Asthenia—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Dicyclomine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Nausea—Prednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Pruritus—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Dicyclomine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Dicyclomine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Dicyclomine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Dicyclomine—Rash—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Dicyclomine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Dicyclomine—Anorexia—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Dicyclomine—Rash—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Dicyclomine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Dicyclomine—Urticaria—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Dicyclomine—Headache—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Dicyclomine—Headache—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Dicyclomine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Dicyclomine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Dicyclomine—Dizziness—Betamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Dicyclomine—Insomnia—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Dicyclomine—Nausea—Triamcinolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Dicyclomine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Dicyclomine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Dicyclomine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Dicyclomine—Somnolence—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Dicyclomine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Dicyclomine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Dicyclomine—Vomiting—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Dicyclomine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Dicyclomine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Dicyclomine—Rash—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Rash—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Fatigue—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Headache—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Headache—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Asthenia—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Pain—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Dicyclomine—Pruritus—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Dicyclomine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Nausea—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Nausea—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Urticaria—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Dicyclomine—Dizziness—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Dicyclomine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Dicyclomine—Vomiting—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Dicyclomine—Rash—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Dicyclomine—Dermatitis—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Dicyclomine—Headache—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Dicyclomine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Dicyclomine—Asthenia—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Dicyclomine—Nausea—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Dicyclomine—Pruritus—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Dicyclomine—Dizziness—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Dicyclomine—Vomiting—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Dicyclomine—Rash—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Dicyclomine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Dicyclomine—Headache—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Dicyclomine—Nausea—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
